1. Home
  2. TAYD vs TLSA Comparison

TAYD vs TLSA Comparison

Compare TAYD & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$53.60

Market Cap

170.7M

Sector

Industrials

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$0.93

Market Cap

155.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAYD
TLSA
Founded
1955
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.7M
155.3M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
TAYD
TLSA
Price
$53.60
$0.93
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$70.00
N/A
AVG Volume (30 Days)
47.3K
256.6K
Earning Date
03-31-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
11.24
N/A
EPS
2.87
N/A
Revenue
$46,292,725.00
N/A
Revenue This Year
$0.25
N/A
Revenue Next Year
$19.78
N/A
P/E Ratio
$18.63
N/A
Revenue Growth
3.84
N/A
52 Week Low
$40.50
$0.91
52 Week High
$90.37
$2.60

Technical Indicators

Market Signals
Indicator
TAYD
TLSA
Relative Strength Index (RSI) 43.01 33.91
Support Level $53.46 N/A
Resistance Level $61.21 $1.48
Average True Range (ATR) 2.53 0.12
MACD -0.39 -0.03
Stochastic Oscillator 11.66 5.17

Price Performance

Historical Comparison
TAYD
TLSA

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: